Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

aurobindo-pharma

Tag: aurobindo pharma

Read all Latest developments, information and news on and about Aurobindo-pharma - Page 16

Aurobindo Pharma is a pharmaceutical manufacturing company headquartered in Hyderabad manufacturing generic pharmaceuticals and active pharmaceutical ingredients. - Latest Updates

Aurobindo Pharma, KAPL get approval for promotion of manufacturing bulk drugs

Ruchika Sharma24 Jan 2021 10:30 AM IST

New Delhi: The government has given approval to drug firms including Aurobindo Pharma and Karnataka Antibiotics & Pharmaceuticals under the...

8 Pharma Firms including Mylan, Aurobindo Pharma to pay Rs 18.25 lakh for allegedly violating green norms

MD Bureau18 Jan 2021 8:03 PM IST

Hyderabad: Violation of pollution control norms has costed eight pharmaceutical units each, including Hetero Labs, Aurobindo Pharma, and Mylan...

Hub for vaccine developers, Hyderabad to hold special significance in 2021

Ruchika Sharma28 Dec 2020 2:40 PM IST

Hyderabad: As the world is set to brace for a new year amid the Covid-19 pandemic, the city is poised to emerge as a 'saviour' from the killer virus,...

Aurobindo Pharma inks pact with US biotech Covaxx to develop COVID-19 vaccine

Ruchika Sharma25 Dec 2020 10:00 AM IST

Hyderabad: Aurobindo Pharma Limited and COVAXX, a US-based company, have entered into an Exclusive License Agreement to develop, commercialize...

Aurobindo Pharma gets USFDA nod for Dexmedetomidine HCL in 0.9% Sodium Chloride Injection

Ruchika Sharma9 Dec 2020 12:59 PM IST

Hyderabad: Pharma major, Aurobindo Pharma Limited, today announced that the company has received final approval from the US Food & Drug...

Aurobindo Pharma completes sale of US subsidiary Natrol LLC to New Mountain Capital

Ruchika Sharma2 Dec 2020 12:27 PM IST

New Delhi: Drug firm Aurobindo Pharma on Tuesday said it has completed the sale of Natrol LLC, a wholly-owned unit of its US-based subsidiary, to...

Aurobindo Pharma expects to commercialise vaccine facility by April-May 2021

Ruchika Sharma1 Dec 2020 11:44 AM IST

New Delhi: Aurobindo Pharma expects to commercialise its vaccine manufacturing facility in Hyderabad by April-May next year, according to a top...

Pfizer pulls Dr Reddys, Aurobindo Pharma to US court over blockbuster cancer drug Ibrance

Ruchika Sharma17 Nov 2020 5:54 PM IST

Pfizer in its petition stated that Aurobindo Pharma and Dr Reddys have submitted ANDA to the USFDA seeking approval to engage in commercial...

4 Indian drugmakers recall various products including Metformin Hydrochloride ER tablets in US

Medical Dialogues Bureau16 Nov 2020 2:46 PM IST

Metformin Hydrochloride extended release tablet is a prescription oral medication indicated as an adjunct to diet and exercise to improve blood...

Aurobindo Pharma shares rise nearly 7 percent after Q2 results

Ruchika Sharma14 Nov 2020 9:30 AM IST

New Delhi: Shares of Aurobindo Pharma on Thursday gained nearly 7 percent in early trade after the company reported a 26 percent increase in...

Aurobindo Pharma to sell US arm to New Mountain Capital for Rs 4,048 crore

Ruchika Sharma26 Oct 2020 12:30 PM IST

The proceeds from Natrol's divestiture will be used to reduce debt and other new strategic initiatives.

Aurobindo Pharma gets USFDA nod to generic equivalent of Ofirmev Injection

Ruchika Sharma24 Oct 2020 10:00 AM IST

Acetaminophen Injection is indicated for the treatment of mild to moderate pain in adult and pediatric patients 2 years and older.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok